The journey of tumor-infiltrating lymphocytes as a biomarker in breast cancer: clinical utility in an era of checkpoint inhibition - Loi, S.; Michiels, S.; Adams, S.; Loibl, Sibylle; Budczies, Jan; Denkert, C.; Salgado, R. (Annals of oncology, 2021)
Gesehen am 29.01.2022